Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000873132 | SCV001015066 | likely benign | Gorlin syndrome | 2024-12-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002444947 | SCV002754094 | likely benign | Hereditary cancer-predisposing syndrome | 2020-06-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV004707443 | SCV005222448 | likely benign | not provided | criteria provided, single submitter | not provided |